Fullerton Healthcare faces delays to IPO after complaints
SGX has received letters outlining concerns about the medical service provider's business, sources say
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
FULLERTON Healthcare Corp, the medical service provider that took orders for its Singapore initial public offering (IPO) last week, is facing delays to the share sale after regulators received complaints, people with knowledge of the matter said.
Singapore regulators are asking Fullerton Healthcare more questions after receiving letters outlining concerns about its business, the sources said, asking not to be identified because the information is private.
Share with us your feedback on BT's products and services
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
